跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.104) 您好!臺灣時間:2026/11/20 05:42
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:楊君鼎
研究生(外文):Chun-Ting Yang
論文名稱:合成(5 -甲基-2-呋喃基)咪唑[4,5-b]吡啶衍生物作為抗血小板藥物
論文名稱(外文):Synthesis of (5-methyl-2-furyl) imidazo [4,5-b]pyridine Derivatives as Antiplatelet Agents
指導教授:連金城連金城引用關係
學位類別:碩士
校院名稱:中國醫藥大學
系所名稱:藥物化學研究所碩士班
學門:醫藥衛生學門
學類:藥學學類
論文種類:學術論文
論文出版年:2012
畢業學年度:100
語文別:中文
論文頁數:154
中文關鍵詞:(5 -甲基-2-呋、喃基)、咪唑[4、5-b]吡、啶
外文關鍵詞:(5-methyl-2-furyl)、imidazo [4、5-b]pyridine
相關次數:
  • 被引用被引用:0
  • 點閱點閱:248
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
在持續研發新型抗血小板凝集的藥物過程中,合成1-benzyl-2-(5-methyl-2-furyl)benzimidazole ( I )並測試其抗血小板活性,結果顯示化合物 I 對於collagen、arachidonic acid、U46619所誘發之血小板凝集具有優越之抑制作用,具發展成為治療栓塞新藥之潛力。於是,本計畫以化合物 I 為先導化合物,設計並合成 5(或 6)-鹵素-1-取代苯甲基-2-(5-甲基-2 -呋喃)咪唑并[4,5-b]吡啶一系列化合物,再經管柱層析分離後,得到的化合物 3~40 進行血小板評估。
本論文旨在從事上述標的化合物之合成及其抗血小板評估,部分標的化合物顯示和化合物 I 相同模式之活性,即對於collagen所引發的血小板凝集具有抑制作用,而化合物 30 亦對於 U46619 (10μM)所誘導之血小板凝集表現出良好抑制活性。此研究結果將增加我們對於benzimidazole衍生物的結構與活性間關係的知識,也期待能找到具抗血小板活性的新化合物。




In continuing development of novel aniplatelet agents, we had found that 1-benzyl-2-(5-methyl-2-furyl)benzimidazole ( I ) showed good platelet inhibitory activity. Compound I showed good inhibitory effect on the platelet aggregation induced by collagen、arachidonic acid、U46619. Encouraged by this result,the Compound I was selected as a lead compound and a series of 5(or 6)-halo-1-substituted benzyl-2-(5-methyl-2-furyl)imidazo[4,5-b]pyridine (3~40) were synthesized in this work. All the synthesized compounds were evaluated for their antiplatelet activities.
In this article, we aim at synthesizing and evaluating their antiplatelet activities. Some of the target compounds showed the same pattern as compound I and exhibited highly inhibitory activity against platelet aggregation induced by collagen. Compound 30 also showed good inhibitory effects on platelet aggregation induced by U46619(10μM). The finding will add to our understanding of SAR of benzimidazoles. The gole of our continuing studies is to identify novel compounds for antiplatelet study.


目錄
圖目錄 Ⅲ
表目錄 Ⅳ
縮寫對照表 Ⅴ
中文摘要 Ⅵ
英文摘要 Ⅶ
第一章 緒論 1
第一節 benzimidazole類化合物之研究概況 1
第二節 Imidazo[4,5-b]pyridine類化合物之研究概況 3
第三節 Benzimidazole類和Imidazo[4,5-b]pyridine類化合物之 合成方法 5
第四節 血小板之生理及病理角色 8
第五節 抗血小板活性藥物之分類 16
第二章 研究動機與目的 19
第三章 結果與討論 24
第一節 化學合成方法 24
第二節 抗血小板活性之藥理結果與討論 32
第四章 結論 36
第五章 實驗部分 37
第一節 試藥來源 37
第二節 重要儀器與實驗材料 39
第三節 各化合物之製備 41
參考文獻 73
圖譜資料 76





























圖目錄
Figure 1 止血機轉過程 10
Figure 2 Arachidonic acid的代謝途徑及其產物 12
Figure 3 抗血小板藥物之機轉 16


表目錄
Table 1 100年國人十大死因 15
Table 2 The Inhibitor Effect of Compound on Platelet Aggregation Induced by ADP, Collagen and Thrombin 19
Table 3 The Inhibitory Effect of Compound I on Platelet Aggregation Induced by U46619,Collagen and arachidonic acid(AA) 20
Table 4 The Inhibitory of Compound I on Fluorescent dye-Induced platelet-rich Thrombus Formation in Mesenteric Venules of Mice 21
Table 5 Effect of Compound I on the bleeding time of mouse tail 22
Table 6 抑制 U46619 所誘導之血小板凝集作用 34
Table 7 抑制 collagen 所誘導之血小板凝集作用 35


1.Subas M. Sakya, Kristin M. Lundy DeMello, Martha L. Minich et al., 5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog, Bioorg. Med. Chem. Lett., 16, 288-292 (2006)

2.Tanitame A., Oyamada Y., Ofuji K., Fujimoto M., Iwai N., Hiyama Y., Suzuki K., Ito H., Terauchi H., Kawasaki M., Nagai K., Wachi M., Yamagishi J., Synthesis and Antibacterial Activity of a Novel Series of Potent DNA Gyrase Inhibitors. Pyrazole Derivatives, J. Med. Chem., 47, 3693-3696 (2004)

3.Bhat B.A., Dhar K.L., Puri S.C., Saxena A.K., Shanmugavel M., Qazi G.N., Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents, Bioorg. Med. Chem. Lett., 15, 3177- 3180 (2005)

4.Adnan A. Bekhit, Hamdy M. Abdel-Rahman, Aida A. Guemei,
Synthesis and Biological Evaluation of Some Hydroxypyrazole Derivatives as Antiinflammatory – Antimicrobial Agents, Arch. Pharm., 339, 81-87 (2006)

5.Michael J. Genin, Carolyn Biles, Barb J. Keiser et al., Novel 1,5-Diphenyl- pyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine- Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives, J. Med. Chem., 43, 1034-1040 (2000)

6.Chimenti F., Maccioni E., Secci D., Bolasco A., Chimenti P. et al., Synthesis, molcular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl- 4,5-dihydro-(1H)-pyrazole derivatives, J. Med. Chem., 48, 7113-7122 (2005)

7.Selwood D.L., Brummell D.G., Budworth J., Burtin G.E. et al., Synthesis and Biological Evaluation of Novel Pyrazoles and Indazoles as Activators of the Nitric Oxide Receptor, Soluble Guanylate Cyclase, J. Med. Chem., 44(1), 78-93 (2001)

8.Gisele A. Nishiguchi, Alice L. Rodriguez and John A. Katzenellenbogen, Diaryl-Dialkyl-Substituted Pyrazoles: Regioselective Synthesis and Binding Affinity for the Estrogen Receptor, Bioorg. Med. Chem. Lett.,12, 947–950 (2002)

9.Hai-Bing Zhou, Kathryn E. Carlson, Fabio Stossi, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Analogs of methyl-piperidinopyrazole (MPP): Antiestrogens with estrogen receptor a selective activity, Bioorg. Med. Chem. Lett. (2008)

10.Shashikanth Ponnala, Devi Prasad Sahu, Iodine-Mediated Synthesis of 2-Arylbenzoxazoles, 2-Arylbenzimidazoles, and 1,3,5- Trisubstituted Pyrazoles, Synth. Commun., 36(15) , pages 2189 – 2194 (2006)

11.Ahmed S., Longchar M., Boruah R. C., Inverse electron demand diels-alder reaction : A facile synthetic route topyrazoles from conjugated oximes utilizing diimides as dipolarophile, Indian journal of chemistry. Sect. B: Org. Synth., 38(2), 125-127 (1999)

12.Jimenez-Cruz F., Hernandez-Ortega S., Ros-Olivares H., Synthesis and molcular structure of the novel monohydrated 3-p- nitrophenylpyrazole derived from 1,3-diketone malonate, J. Mol. Struct., 650, 223–231 (2003)

13.Suryakiran N., Srikanth Reddy T., Asha Latha K., Prabhakar P., Yadagiri K., Venkateswarlu Y., An expeditious synthesis of 3-amino 2H-pyrazoles promoted by methanesulphonic acid under solvent and solvent free conditions, J. Mol. Catal., 258, 371–375 (2006)

14.Faller A., Schuenke M., Thieme, The Human Body, 279-281 (2004)



15.Baumgartner H.P., Muggli R., Tschopp T.B. and Turitto V.T., Platelet adhension, release and aggregation in flowing blood : effects of surface properties and platelet function. Thromb. haemost., 35, 124-138 (1976)

16.Stemerman M.B., Baumgartner H.R. and Spaet T.H., The subendothelial microfibril and adhesion. Lab. Invest., 24, 176-186 (1972)

17.Malmsten C., Hamberg M., Svensson J., and Samuelsson B., Physiological role of and endoperoxide in human platelets:Hemostatic defect due to cyclooxygenase deficiency., Proc. Natl. Acad. Sci., 72, 1446-8 (1975)

18.Billes T., Smith J. B., and Silver M. J., Metabolism of 14C – arachidonic acid by human platelets., Biochem. Biophys. Acta, 241, 303-14 (1976)

19.Shepherd J. T. and Katusic Z. S., Endothelium derived vasoactive factors: Endothelium-dependent relaxation, Hypertension, 18 (Suppl.III): 76-85 (1991)

20.Huang E. M. and Detwiler W. D., Stimulus-response coupling mechanism, Orlande FL, Academic Press, Pl-68 (1986)

21.Waldman S. A., and Murad F., Cyclic GMP synthesis and function, Pharmacol Rev., 39, 163-96 (1987)

22.Coller B. S., Antiplatelet agents in the prevention and therapy of thrombosis. Annu. Rev. Med., 43, 171-80 (1992)

23.Shaun P. Jackson & Simone M. Schoenwaelder, Antiplatelet therapy: in search of the ''magic bullet''. Nat. Rev. Drug. Discov., 775-789 (2003)

24.Philip W. M., George J. B., Joseph P. M., and Douglas M. T.: Anticoagulant, Thrombolytic, and Antiplatelet Drugs. in Goodman and Gilman’s (eds): The Pharmacological Basis of Therapeutic. New York : Pergamon Press, Chap. 55, 1311-31 (1990)


QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top